Massachusetts H3757 prohibits insurers from requiring annual re-authorizations for certain prescription drugs.
Massachusetts H3757 aims to prevent insurers from demanding annual re-authorizations for specific prescription drugs. This bill targets licensed health insurers operating under chapters 32A, 118E, 175, 176A, 176B, or 176G of the General Laws. The legislation specifically addresses prescription drugs prescribed to treat chronic diseases such as diabetes, heart disease, Alzheimer's disease, cancer, stroke, and respiratory disease.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.